NCT04204252Phase 3Terminated

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Study sponsor: Kamada, Ltd. · KMDA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-02-19Actual
Enrollment · participants98Actual
Source updated2026-08-12Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 220 participants (planned). After: 98 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2028. After: 19 Feb 2026.

Recruitment status changed

Before: Recruiting. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview